Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Theravance Biopharma (TBPH) Receivables - Net (2016 - 2019)

Theravance Biopharma (TBPH) has disclosed Receivables - Net for 7 consecutive years, with $87000.0 as the latest value for Q3 2019.

  • On a quarterly basis, Receivables - Net fell 97.12% to $87000.0 in Q3 2019 year-over-year; TTM through Sep 2019 was $87000.0, a 97.12% decrease, with the full-year FY2018 number at $620000.0, down 72.48% from a year prior.
  • Receivables - Net was $87000.0 for Q3 2019 at Theravance Biopharma, down from $111000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $3.4 million in Q2 2018 to a low of $87000.0 in Q3 2019.
  • A 5-year average of $1.3 million and a median of $1.2 million in 2017 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: soared 18733.33% in 2015, then tumbled 97.12% in 2019.
  • Theravance Biopharma's Receivables - Net stood at $1.9 million in 2015, then plummeted by 66.39% to $646000.0 in 2016, then soared by 248.76% to $2.3 million in 2017, then crashed by 72.48% to $620000.0 in 2018, then tumbled by 85.97% to $87000.0 in 2019.
  • Per Business Quant, the three most recent readings for TBPH's Receivables - Net are $87000.0 (Q3 2019), $111000.0 (Q2 2019), and $113000.0 (Q1 2019).